Wednesday - April 29, 2026

Category Archives: Professional Services

Shrewsbury, Mass. Realtor Maribeth McCauley Lynch Named to Boston Agent Magazine’s “Who’s Who in Boston Real Estate 2026”

SHREWSBURY, Mass. – April 28, 2026 – Maribeth McCauley Lynch, broker associate and Realtor with Lamacchia Realty in Shrewsbury, has been named to Boston Agent Magazine’s “Who’s Who in Boston Real Estate 2026,” an exclusive feature recognizing top-performing real estate professionals … Continue reading →

Evergreen Chimney Service Highlights the Importance of Chimney Caps for Home Protection in Sherwood, Oregon in 2026

Evergreen Chimney Service is educating Sherwood, Oregon homeowners on the critical role chimney caps play in protecting homes. The company explains how chimney inspection, chimney sweep, chimney repair, and chimney cap installation help prevent damage, improve safety, and extend chimney … Continue reading →

Type 1 Diabetes Treatment Pipeline Shows Strong Momentum as 85+ Pharma Companies in the Race | DelveInsight

DelveInsight’s, “Type 1 Diabetes Pipeline Insight, 2026” report provides comprehensive insights about 85+ companies and 100+ pipeline drugs in Type 1 Diabetes pipeline landscape. It covers the Type 1 Diabetes pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading →

Chronic Myeloid Leukemia Pipeline Grows as 20+ Pharma Companies Advance Novel Blood Cancer Therapies, Finds DelveInsight | Renascience, Novartis Pharmaceuticals, Terns Pharmaceuticals

Chronic Myeloid Leukemia (CML) Pipeline Insights There are 20+ key companies, including Renascience, Novartis Pharmaceuticals, Terns Pharmaceuticals, Enliven Therapeutics, MacroGenics, Kartos Therapeutics, AOP Orphan Pharmaceuticals, and others, developing therapies for Chronic Myeloid Leukemia, with Renascience having its CML drug candidate … Continue reading →

Crohn’s Disease Pipeline Shows Strong Momentum as 90+ Pharma Companies Advance Novel Inflammatory Bowel Disease Therapies, Finds DelveInsight | AbbVie, Janssen, Merck, Takeda, Roche

Crohn’s Disease Pipeline Insight There are 90+ key companies, including AbbVie, Janssen, Merck, Takeda, Roche, AgomAb Therapeutics, Pfizer, Amgen, and others, developing therapies for Crohn’s disease, with companies like Janssen and Roche having candidates in the most advanced Phase III … Continue reading →

wAIHA Treatment Landscape: FDA Grants Priority Review to IMAAVY, Potential First Approved Therapy | Industry Insights on Market Impact, Competitive Landscape and Pipeline

Beyond wAIHA, nipocalimab is being studied in several other autoantibody-mediated diseases, including Sjögren’s disease, lupus, and generalized myasthenia gravis (where it is already approved). This multi-indication potential highlights the versatility of FcRn inhibition as a therapeutic platform for rare and … Continue reading →

Postoperative Pain Pipeline Enters a New Era with 50+ Therapies and 40+ Companies Driving Innovation in Multimodal Analgesia and Long-Acting Pain Relief | DelveInsight

Postoperative Pain Pipeline Key Postoperative Pain Companies are Ensysce Biosciences, Nevakar, Sustained Therapeutics, Concentric Analgesics, G2GBIO, LipoCure, Bexson Biomedical, Allay Therapeutics, and others The Postoperative Pain therapeutic landscape is undergoing a significant transformation, driven by a surge in innovative drug … Continue reading →

Pancreatic Cancer Pipeline Enters a New Era of Precision Oncology with 200+ Therapies and 170+ Companies Advancing Next-Generation Treatments | DelveInsight

Pancreatic Cancer Pipeline Key Pancreatic Cancer Companies are Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd., Oncotelic Inc., Golden Biotechnology Corp., Cantargia AB, Marker Therapeutics, NanoPharmaceuticals, Innovent Biologics, Takeda, Merck, Agenus, and others The pancreatic cancer therapeutic landscape is … Continue reading →